‘The enemy of my enemy is my friend:’ Couple turns to viruses to beat back superbug

Man with desperate infection rescued 100 years after Canadian co-discovery of phages By Amina Zafar, CBC News Posted: Apr 28, 2017 8:14 PM ET Last Updated: Apr 29, 2017 7:32 AM ET – Link here It may seem like an unlikely option, but it was viruses that helped to save Tom Patterson when a superbug threatened his life. Patterson fell […]

AmpliPhi Biosciences Announces Presentation of Personalized Bacteriophage Therapy Case Study for Life-Threatening Antibiotic-Resistant Infection at Scientific Conference

Tuesday, April 25, 2017 6:50 am EDT – Link here SAN DIEGO EmailPDFPrintRSS PUBLIC COMPANY INFORMATION: NYSEMKT: APHB “Intravenous applications of phage therapy to treat a terminally ill patient who was infected with a multidrug-resistant A. baumannii” SAN DIEGO–(BUSINESS WIRE)–AmpliPhi Biosciences Corporation (NYSE MKT: APHB), a global leader in the development of therapies for drug-resistant […]

AmpliPhi Biosciences Announces Positive Feedback from FDA on Phase 2 Development Proposal

Monday, April 17, 2017 9:00 am EDT – Link here SAN DIEGO EmailPDFPrintRSS PUBLIC COMPANY INFORMATION: NYSEMKT: APHB “I’m extremely proud of the entire AmpliPhi team, including academic collaborators, clinical investigators and consultants, for their efforts in successfully positioning our phage technology to enter the Phase 2 development stage, which we expect will open additional […]

AmpliPhi Biosciences Announces Planned One-for-Ten Reverse Stock Split

Friday, April 14, 2017 5:00 pm EDT – Link here SAN DIEGO EmailPDFPrintRSS PUBLIC COMPANY INFORMATION: NYSEMKT: APHB “We believe the increased market price of our common stock expected to result following the implementation of the reverse stock split may improve the marketability and liquidity of our common stock and encourage interest and trading in […]

Zoetis to Acquire Nexvet Biopharma, an Innovator in Monoclonal Antibody Therapies for Companion Animals

Purchase price of US$6.72 per share, or approximately US$85 million in aggregate Acquisition to strengthen Zoetis’ pipeline in companion animal therapeutics for chronic pain, a global area estimated at US$400 million annually1 PARSIPPANY, N.J. & TULLAMORE, Ireland–(BUSINESS WIRE)–Apr. 13, 2017– Link here Zoetis Inc. (NYSE:ZTS) and Nexvet Biopharma plc (Nasdaq:NVET) today announced an agreement in which Zoetis, through a wholly owned subsidiary (“Zoetis Bidco”), will purchase […]

FDA Approves Increased Compassionate Use Patient Cases and Sites for ReCell®

Valencia, CA, Perth, Australia and London, United Kingdom, 7 April 2017 – link here The U.S. Food and Drug Administration has approved a further increase in the number of patients who can be treated in the United States with the ReCell® regenerative medical device under a compassionate use protocol, Avita Medical Ltd. (ASX: AVH), (OTCQX: […]

AmpliPhi Biosciences Announces Presentations of Clinical and Preclinical Data from Studies with its Bacteriophage Technology at Two Scientific Conferences

CATEGORY: Featured Tuesday, April 4, 2017 6:50 am EDT – link here SAN DIEGO EmailPDFPrintRSS PUBLIC COMPANY INFORMATION: NYSEMKT: APHB “AmpliPhi and our partners have produced promising clinical and nonclinical data demonstrating AmpliPhi’s phage cocktails are safe and active against a broad footprint of isolates, including those that are multidrug-resistant” SAN DIEGO–(BUSINESS WIRE)–AmpliPhi Biosciences Corporation […]